Wein Matthew (CIK 2009713) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-10). Recent activity: Sell MGX (558 shares), Buy MGX (11,000 shares), Sell MGX (482 shares), Sell MGX (199 shares), Sell MGX (199 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Metagenomi Therapeutics, Inc. (MGX) | See Remarks | Sell | 558 | $725 |
| 2026-04-03 | Metagenomi Therapeutics, Inc. (MGX) | See Remarks | Buy | 11,000 | $0 |
| 2026-03-09 | Metagenomi Therapeutics, Inc. (MGX) | See Remarks | Sell | 482 | $771 |
| 2025-12-08 | Metagenomi, Inc. (MGX) | See Remarks | Sell | 199 | $352 |
| 2025-12-01 | Metagenomi, Inc. (MGX) | See Remarks | Sell | 199 | $360 |
| 2025-12-01 | Metagenomi, Inc. (MGX) | See Remarks | Buy | 96,000 | $153,600 |
| 2025-06-09 | Metagenomi, Inc. (MGX) | See Remarks | Sell | 199 | $348 |
| 2025-04-03 | Metagenomi, Inc. (MGX) | See Remarks | Buy | 3,650 | $0 |
| 2025-04-03 | Metagenomi, Inc. (MGX) | See Remarks | Buy | 3,775 | $0 |
| 2025-03-07 | Metagenomi, Inc. (MGX) | See Remarks | Sell | 930 | $1,739 |
Source: SEC Form 4 filings · as of 2026-06-10